Cambridge researchers identify “hidden” gut microbes to unlock next-gen probiotics
UK research has found that healthy people’s gut microbiomes consistently have higher levels of the bacterial group CAG-170 than those with diseases such as inflammatory bowel disease and obesity. It reveals the importance of understanding the “hidden microbiome,” such as this bacterial group, to foster new therapeutics.Nutrition Insight speaks with the lead researcher from the University of Cambridge to discuss the potential of CAG-170 to spur probiotic innovation and how the probiotics industry should broaden its applications beyond the well-known Bifidobacterium and Lactobacillus.This Technical Paper is brought to you by Arjuna Natural.
Kara Siedman, senior director of partnerships at Resbiotic, introduces the osteobiotic ResO, a postbiotic-based ingredient designed to support gut health, immunity, and joint mobility. She explains how it differs from traditional glucosamine or collagen supplements, highlights the role the RSB11 postbiotic plays in the formula, shares clinical evidence for mobility benefits, and outlines Resbiotic’s long-term vision for gut-based health solutions.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Women's health redefined Feb 2026

GLP-1 weight management trendsFeb 2026
Multimedia
Billie Ivanova, marketing and communications manager at Solabia Nutrition, discusses Brainberry, a standardized aronia extract. She explains what makes the “Nero Eggert” variety of aronia uniquely suited for cognitive health, while sharing how the ingredient crosses the blood-brain barrier to...





























